Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$3.58M Buy
29,762
+2,034
+7% +$238K 0.15% 110
2026
Q1
$2.92M Sell
27,728
-110
-0.4% -$12.7K 0.14% 96
2025
Q4
$2.93M Sell
27,838
-1,500
-5% -$141K 0.14% 97
2025
Q3
$2.46M Buy
29,338
+12,712
+76% +$1.05M 0.13% 98
2025
Q2
$1.32M Buy
16,626
+8,227
+98% +$654K 0.08% 143
2025
Q1
$754K Buy
8,399
+993
+13% +$92.7K 0.05% 170
2024
Q4
$737K Buy
7,406
+1,023
+16% +$105K 0.06% 153
2024
Q3
$725K Buy
6,383
+707
+12% +$84K 0.06% 120
2024
Q2
$703K Buy
5,676
+1,200
+27% +$155K 0.07% 113
2024
Q1
$591K Sell
4,476
-159
-3% -$19.6K 0.07% 105
2023
Q4
$505K Buy
4,635
+56
+1% +$5.81K 0.08% 120
2023
Q3
$471K Buy
4,579
+545
+14% +$58.7K 0.09% 116
2023
Q2
$465K Buy
4,034
+2
+0% +$227 0.09% 118
2023
Q1
$429K Sell
4,032
-734
-15% -$79.2K 0.09% 119
2022
Q4
$529K Buy
4,766
+251
+6% +$25.7K 0.12% 100
2022
Q3
$389K Sell
4,515
-170
-4% -$15.2K 0.1% 116
2022
Q2
$427K Buy
4,685
+48
+1% +$4.25K 0.11% 116
2022
Q1
$380K Sell
4,637
-3,494
-43% -$275K 0.09% 123
2021
Q4
$623K Sell
8,131
-550
-6% -$43.8K 0.13% 107
2021
Q3
$652K Buy
8,681
+3,705
+74% +$282K 0.15% 88
2021
Q2
$387K Sell
4,976
-232
-4% -$17.3K 0.13% 107
2021
Q1
$383K Buy
5,208
+1,276
+32% +$94.1K 0.14% 100
2020
Q4
$307K Buy
+3,932
New +$301K 0.14% 97

Other funds holding MRK

Sax Wealth Advisors's MRK Position: Q2 2026 in Review

Sax Wealth Advisors increased its Merck (MRK) stake by 7.3% in Q2 2026, buying an estimated $238K and bringing the position to 29,762 shares worth $3.58M. The position accounts for 0.15% of the portfolio, ranked #110.

Sax Wealth Advisors first reported a position in MRK in Q4 2020 and has held it in 23 quarters since. 1,867 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

  • Sax Wealth Advisors held 29,762 shares of Merck worth $3.58M as of Q2 2026.
  • Sax Wealth Advisors bought 2,034 Merck shares in Q2 2026, an estimated $238K.
  • Merck made up 0.15% of Sax Wealth Advisors's portfolio in Q2 2026, its #110 holding.
  • Sax Wealth Advisors first reported a position in Merck in Q4 2020 and has held it in 23 quarters since.
  • 1,867 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on Sax Wealth Advisors's 13F filing for Q2 2026, filed 9 Jul 2026.